Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2026 on…

Results from the Phase 1b dose escalation of the TheraPb clinical trial (NCT05720130) presented at…

Preclinical evaluation and preliminary human imaging of a novel 212Pb-based, PSMA-targeted radioligand, 212Pb-ADVC001, for prostate…

Despite an increase in the number of approved therapies for metastatic castration- resistant prostate cancer…

Source: AdvanCell First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer There…